Reversal of multidrug resistance.
Kaye
S B
SB
CRC Department of Medical Oncology, University of Glasgow, U.K.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004351:Drug Resistance; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy; D011485:Protein Binding / Q000187:drug effects; D014700:Verapamil / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D008562:Membrane Glycoproteins; D014700:Verapamil; D004250:DNA Topoisomerases, Type II; D005978:Glutathione